GENNEX LABORATORIES LTD. - Board Meeting Outcome for Outcome Of The Board Meeting Held On January 04, 2022 Of Gennex Laboratories Limited

Download	< Back
04 Jan 2022
In just concluded Meeting of the Board Directors of the Company, the board has considered and approved: 1. After through discussion on all the recommendations of the Audit Committee, board decided to make Deccan Remedies Limited (Deccan) as our Subsidiary Company by acquire additional 6.73% equity Shares i.e., 836,165 from the Existing promoter Shareholders group and in turn the Company will hold 51% equity shares of the Deccan. 2. Mr. Arihant Baid, Managing Director of the Company represent Gennex (the Company) in the Board of Deccan to manage the Affairs of the Deccan.
View all announcements for GENNEX LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us